Asymptomatic Child Pugh A5 To B8 Cirrhosis clinical trials

Explore recruiting asymptomatic child pugh a5 to b8 cirrhosis clinical trials.

Also recruiting in Europe

Asymptomatic Child Pugh A5 To B8 Cirrhosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of long-term carvedilol to prevent decompensation or death in patients with asymptomatic Child-Pugh A5 to B8 cirrhosis and clinically significant portal hypertension: a multicenter, double-blind, randomized controlled trial.

France

Therapeutic use (Phase IV) EU CTIS Study details

Asymptomatic Child Pugh A5 To B8 Cirrhosis trials by city

Asymptomatic Child Pugh A5 To B8 Cirrhosis in Toronto Asymptomatic Child Pugh A5 To B8 Cirrhosis in Vancouver Asymptomatic Child Pugh A5 To B8 Cirrhosis in Montreal Asymptomatic Child Pugh A5 To B8 Cirrhosis in Calgary Asymptomatic Child Pugh A5 To B8 Cirrhosis in Edmonton Asymptomatic Child Pugh A5 To B8 Cirrhosis in Ottawa Asymptomatic Child Pugh A5 To B8 Cirrhosis in Winnipeg Asymptomatic Child Pugh A5 To B8 Cirrhosis in Quebec City Asymptomatic Child Pugh A5 To B8 Cirrhosis in Hamilton Asymptomatic Child Pugh A5 To B8 Cirrhosis in Kitchener Asymptomatic Child Pugh A5 To B8 Cirrhosis in London Asymptomatic Child Pugh A5 To B8 Cirrhosis in Halifax Asymptomatic Child Pugh A5 To B8 Cirrhosis in New York Asymptomatic Child Pugh A5 To B8 Cirrhosis in Los Angeles Asymptomatic Child Pugh A5 To B8 Cirrhosis in Chicago Asymptomatic Child Pugh A5 To B8 Cirrhosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease